Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01628718 · ClinicalTrials.gov registry record · NA
Adaptive Disclosure: A Combat-Specific PTSD Treatment
A NA study, sponsored by Veterans Medical Research Foundation.
- Completed
- Registry status
- NA
- Development phase
- 122
- Enrollment target
NCT01628718 is a NA study that has completed, run by Veterans Medical Research Foundation. The registered enrollment target is 122 participants.
The verdict
NCT01628718, a NA study, has completed, sponsored by Veterans Medical Research Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 122 participants
- Enrollment target
Study Summary
The primary objective of this randomized controlled non-inferiority trial is to determine whether or not Adaptive Disclosure (AD), a new combat-specific psychotherapy for Post Traumatic Stress Disorder (PTSD), is as least as effective as Cognitive Processing Therapy, cognitive only version (CPT-C), in terms of its impact on deployment-related psychological health problems (specifically PTSD and depression) and functioning.
Interventions
- BEHAVIORAL Adaptive Disclosure (AD)
- BEHAVIORAL Cognitive Processing Therapy, cognitive version only (CPT-C)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2013-03 |
| Est. Completion | 2019-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01628718
The ClinicalTrials.gov registry entry for NCT01628718 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Veterans Medical Research Foundation, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Adaptive Disclosure (AD) is the first listed.
NCT01628718 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01628718 about?
NCT01628718 is a clinical study titled "Adaptive Disclosure: A Combat-Specific PTSD Treatment". The primary objective of this randomized controlled non-inferiority trial is to determine whether or not Adaptive Disclosure (AD), a new combat-specific psychotherapy for Post Traumatic Stress Disorder (PTSD), is as least as effective as Cognitive Processing Therapy, cognitive only version (CPT-C), ...
What is the current status of trial NCT01628718?
This trial is currently completed. It is a NA study. The enrollment target is 122 participants. The study started on 2013-03. Estimated completion is 2019-07.
What interventions are being tested in trial NCT01628718?
The interventions under investigation include: Adaptive Disclosure (AD) (BEHAVIORAL), Cognitive Processing Therapy, cognitive version only (CPT-C) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01628718?
This trial is sponsored by Veterans Medical Research Foundation, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.